Votruba Michal has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 17000 shares of BioXcel Therapeutics, Inc. ($BTAI) on January 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Votruba Michal | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| June 10, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Votruba Michal | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| June 10, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Votruba Michal | Director | J | Stock Option (Right to Buy) | 17000 | $0.00 | 0.0000 | 1,929,000 | 100.00% | 0.88% |
| June 26, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Votruba Michal | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |
| June 26, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Votruba Michal | Director | J | Stock Option (Right to Buy) | 17000 | $0.00 | 0.0000 | 28,616,000 | 100.00% | 0.06% |